Literature DB >> 10913180

Receptor isoforms mediate opposing proliferative effects through gbetagamma-activated p38 or Akt pathways.

L A Sellers1, F Alderton, A M Carruthers, M Schindler, P P Humphrey.   

Abstract

The opposing effects on proliferation mediated by G-protein-coupled receptor isoforms differing in their COOH termini could be correlated with the abilities of the receptors to differentially activate p38, implicated in apoptotic events, or phosphatidylinositol 3-kinase (PI 3-K), which provides a source of survival signals. These contrasting growth responses of the somatostatin sst(2) receptor isoforms, which couple to identical Galpha subunit pools (Galpha(i3) > Galpha(i2) >> Galpha(0)), were both inhibited following betagamma sequestration. The sst(2(a)) receptor-mediated ATF-2 activation and inhibition of proliferation induced by basic fibroblast growth factor (bFGF) were dependent on prolonged phosphorylation of p38. In contrast, cell proliferation and the associated transient phosphorylation of Akt and p70(rsk) induced by sst(2(b)) receptors were blocked by the PI 3-K inhibitor LY 294002. Stimulation with bFGF alone had no effect on the activity of either p38 or Akt but markedly enhanced p38 phosphorylation mediated by sst(2(a)) receptors, suggesting that a complex interplay exists between the transduction cascades activated by these distinct receptor types. In addition, although all receptors mediated a sustained activation of extracellular signal-regulated kinases (ERK1 and ERK2), induction of the tumor suppressor p21(cip1) was detected only following amplification of ERK and p38 phosphorylation by concomitant bFGF and sst(2(a)) receptor activation. Expression of constitutively active Akt in the presence of a p38 inhibitor enabled a proliferative response to be detected in sst(2(a)) receptor-expressing cells. These findings demonstrate that the duration of activation and a critical balance between the mitogen-activated protein kinase and PI 3-K pathways are important for controlling cell proliferation and that the COOH termini of the sst(2) receptor isoforms may determine the selection of appropriate betagamma-pairings necessary for interaction with distinct kinase cascades.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10913180      PMCID: PMC86074          DOI: 10.1128/MCB.20.16.5974-5985.2000

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  56 in total

Review 1.  7TM receptors: the splicing on the cake.

Authors:  G J Kilpatrick; F M Dautzenberg; G R Martin; R M Eglen
Journal:  Trends Pharmacol Sci       Date:  1999-07       Impact factor: 14.819

2.  Somatostatin activation of mitogen-activated protein kinase via somatostatin receptor 1 (SSTR1).

Authors:  T Florio; H Yao; K D Carey; T J Dillon; P J Stork
Journal:  Mol Endocrinol       Date:  1999-01

3.  Signals from Ras and Rho GTPases interact to regulate expression of p21Waf1/Cip1.

Authors:  M F Olson; H F Paterson; C J Marshall
Journal:  Nature       Date:  1998-07-16       Impact factor: 49.962

4.  p38 mitogen-activated protein kinase activation is required for fibroblast growth factor-2-stimulated cell proliferation but not differentiation.

Authors:  P Maher
Journal:  J Biol Chem       Date:  1999-06-18       Impact factor: 5.157

5.  Prolonged activation of extracellular signal-regulated kinase by a protein kinase C-dependent and N17Ras-insensitive mechanism mediates the proliferative response of G(i/o)-coupled somatostatin sst(4) receptors.

Authors:  L A Sellers
Journal:  J Biol Chem       Date:  1999-08-20       Impact factor: 5.157

6.  Involvement of p38 mitogen-activated protein kinase in basic fibroblast growth factor-induced interleukin-6 synthesis in osteoblasts.

Authors:  O Kozawa; H Tokuda; H Matsuno; T Uematsu
Journal:  J Cell Biochem       Date:  1999-09-01       Impact factor: 4.429

7.  PI 3-kinase gamma and protein kinase C-zeta mediate RAS-independent activation of MAP kinase by a Gi protein-coupled receptor.

Authors:  H Takeda; T Matozaki; T Takada; T Noguchi; T Yamao; M Tsuda; F Ochi; K Fukunaga; K Inagaki; M Kasuga
Journal:  EMBO J       Date:  1999-01-15       Impact factor: 11.598

8.  Molecular cloning and functional characterization of a rat somatostatin sst2(b) receptor splice variant.

Authors:  M Schindler; E J Kidd; A M Carruthers; M A Wyatt; E M Jarvie; L A Sellers; W Feniuk; P P Humphrey
Journal:  Br J Pharmacol       Date:  1998-09       Impact factor: 8.739

9.  Distinct neurite outgrowth signaling pathways converge on ERK activation.

Authors:  J C Perron; J L Bixby
Journal:  Mol Cell Neurosci       Date:  1999-05       Impact factor: 4.626

10.  Roles of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase in the signal transduction of basic fibroblast growth factor in endothelial cells during angiogenesis.

Authors:  K Tanaka; M Abe; Y Sato
Journal:  Jpn J Cancer Res       Date:  1999-06
View more
  9 in total

1.  Differential somatostatin receptor (SSTR) 1-5 expression and downstream effectors in histologic subtypes of growth hormone pituitary tumors.

Authors:  Katja Kiseljak-Vassiliades; Mei Xu; Taylor S Mills; Elizabeth E Smith; Lori J Silveira; Kevin O Lillehei; Janice M Kerr; B K Kleinschmidt-DeMasters; Margaret E Wierman
Journal:  Mol Cell Endocrinol       Date:  2015-09-21       Impact factor: 4.102

2.  Somatostatin stimulates intestinal NHE8 expression via p38 MAPK pathway.

Authors:  Chunhui Wang; Hua Xu; Huacong Chen; Jing Li; Bo Zhang; Chengwei Tang; Fayez K Ghishan
Journal:  Am J Physiol Cell Physiol       Date:  2010-11-24       Impact factor: 4.249

Review 3.  Drug design at peptide receptors: somatostatin receptor ligands.

Authors:  Jason P Hannon; Caroline Nunn; Barbara Stolz; Christians Bruns; Gisbert Weckbecker; Ian Lewis; Thomas Troxler; Konstanze Hurth; Daniel Hoyer
Journal:  J Mol Neurosci       Date:  2002 Feb-Apr       Impact factor: 3.444

4.  Molecular mechanisms mediating the G protein-coupled receptor regulation of cell cycle progression.

Authors:  David C New; Yung H Wong
Journal:  J Mol Signal       Date:  2007-02-26

5.  Role of somatostatin receptor-2 in gentamicin-induced auditory hair cell loss in the Mammalian inner ear.

Authors:  Yves Brand; Vesna Radojevic; Michael Sung; Eric Wei; Cristian Setz; Andrea Glutz; Katharina Leitmeyer; Daniel Bodmer
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

Review 6.  Somatostatin Receptors and Analogs in Pheochromocytoma and Paraganglioma: Old Players in a New Precision Medicine World.

Authors:  Mayank Patel; Isabel Tena; Abhishek Jha; David Taieb; Karel Pacak
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-29       Impact factor: 5.555

Review 7.  Targeting GPCRs and Their Signaling as a Therapeutic Option in Melanoma.

Authors:  Jérémy H Raymond; Zackie Aktary; Lionel Larue; Véronique Delmas
Journal:  Cancers (Basel)       Date:  2022-01-29       Impact factor: 6.639

Review 8.  PI3K-AKT-mTOR-signaling and beyond: the complex network in gastroenteropancreatic neuroendocrine neoplasms.

Authors:  Franziska Briest; Patricia Grabowski
Journal:  Theranostics       Date:  2014-01-29       Impact factor: 11.556

Review 9.  Pasireotide: a novel treatment for patients with acromegaly.

Authors:  Daniel Cuevas-Ramos; Maria Fleseriu
Journal:  Drug Des Devel Ther       Date:  2016-01-11       Impact factor: 4.162

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.